AllianceBernstein
SPPI

AllianceBernstein’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AllianceBernstein’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-85,000
Closed -$1.43M – 3160
2018
Q3 		$1.43M Buy
+85,000
New +$1.84M ﹤0.01% 2150

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

AllianceBernstein's SPPI Position: Q2 2022 in Review

AllianceBernstein sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 208,565 shares — an estimated $269K sold.

AllianceBernstein first reported a position in SPPI in Q2 2013 and held it in 36 quarters. The position peaked at $4.48M in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • AllianceBernstein reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 208,565 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $269K.
  • AllianceBernstein first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 36 quarters.
  • AllianceBernstein's Spectrum Pharmaceuticals Inc position peaked at $4.48M in Q2 2018.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.